Literature DB >> 22475975

Acquired cholesteatoma in children: strategies and medium-term results.

A Drahy1, A De Barros, Y Lerosey, O Choussy, D Dehesdin, J-P Marie.   

Abstract

OBJECTIVES: To assess paediatric cholesteatoma surgical management strategies, residual disease and recurrence rates and especially the medium-term auditory impact.
MATERIAL AND METHODS: Retrospective study of 22 cases of acquired middle ear cholesteatoma selected from a series of 77 children under the age of 16 operated for cholesteatoma between 1st January 2000 and 31st December 2003 on the basis of the following criteria: first-line surgical management with postoperative follow-up greater than four years. Surgical strategies, preoperative and postoperative (at 1 year and at the final visit) audiograms and residual disease and recurrence rates were analysed.
RESULTS: A canal wall up tympanoplasty was performed in 82% of cases as first-line procedure and a canal wall down tympanoplasty was performed in 32% of cases. Residual cholesteatoma was observed in 9% of cases and recurrent disease was observed in 18% of cases. The mean preoperative hearing loss was 26dB with an air-bone gap of 23dB with values of 26dB and 20dB respectively at the end of follow-up.
CONCLUSION: The majority of children were operated by two-stage canal wall up tympanoplasty. Long-term hearing results remained stable and close to preoperative values. The recurrence rate (residual disease and relapse) was low (27%), as reported in the literature.
Copyright © 2012. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2012        PMID: 22475975     DOI: 10.1016/j.anorl.2011.10.011

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  3 in total

1.  Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.

Authors:  Yuka Morita; Yutaka Yamamoto; Shinsuke Oshima; Kuniyuki Takahashi; Sugata Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

2.  The utility of minimally invasive transcanal endoscopic approach for removal of residual/recurrent cholesteatoma: preliminary results.

Authors:  Lela Migirov; Arkadi Yakirevitch; Michael Wolf
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-21       Impact factor: 2.503

3.  MDCT of the temporal bone and audiological findings of pediatric acquired cholesteatoma.

Authors:  Asli Tanrivermis Sayit; Dilek Saglam; Hediye Pinar Gunbey; Mustafa Tastan; Cetin Celenk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-21       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.